Investor Presentaiton
Committed to Driving Scientific Advancement
Focused on ensuring patient safety and reducing animal use
Advancing the 4Rs
Microbial business launched EndosafeⓇ Trillium®, our new animal-free
recombinant test for endotoxin detection, in July 2023
Invest in innovation to broaden our reach through strategic partnerships for
cutting-edge technologies that promote in vitro methods
Partnerships with BitBio (iPSC-derived human cells) and Cypre (3D tumor modeling
platform; immuno-oncology assays)
Partnered with PathoQuest in 2020 to access an in vitro next-generation sequencing
(NGS) platform for viral safety testing
Virtual control groups (VCGs) as an alternative to animals in toxicity studies, to
reduce animal usage, lower costs, free capacity, and increase statistical power
Charles River Laboratories (CRL)
7View entire presentation